Transplantation of adult stem cells improve short-term cardiac function post-MI, yet excreted paracrine factors, such as vascular endothelial growth factor (VEGF) and insulin growth factor 1 (IGF1) account for this therapeutic improvement4. The gene discussed is IGF1; the disease is myocardial infarction.